Long-Term Natural History of Treatment-Naïve Geographic Atrophy in Age-Related Macular Degeneration
By analyzing the data of one of the most extensive geographic atrophy patient cohorts in the Nordics, this study establishes a dataset on the long-term treatment-naïve growth dynamics. It provides a reference for upcoming preclinical treatment developments and clinical trial end points.
Authors
- Laurence Quérat (ORCID: https://orcid.org/0000-0002-8878-1600)
- Sandrine Zweifel (ORCID: https://orcid.org/0000-0001-7431-1774)
- Pete A. Williams (ORCID: https://orcid.org/0000-0001-6194-8397)
- Anders Kvanta (ORCID: https://orcid.org/0000-0003-2194-7490)
- Alberto Domínguez‐Vicent (ORCID: https://orcid.org/0009-0005-1947-8009)
- Filippo Locri (ORCID: https://orcid.org/0009-0000-3772-8730)
- Daniel Rudolf Muth (ORCID: https://orcid.org/0000-0003-3670-976X)
- Abinaya Priya Venkataraman (ORCID: https://orcid.org/0000-0002-2155-7030)
- Goran Petrovski
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- University of Zurich (CH)
- University "St. Kliment Ohridski" - Bitola (MK)
- Karolinska Institutet (SE)
- University Hospital of Zurich (CH)
- S:t Eriks Ögonsjukhus (SE)
- University of Split (HR)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1167/tvst.14.5.5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Apellis Pharmaceuticals
- Santen
- Vetenskapsrådet
- Astellas Pharma
- S:t Eriks Ögonforskningsstiftelse
- Allergan